Related Experiment Video
Updated: Aug 28, 2025

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Treatment of membranous nephropathy with crescent nephritis by rituximab: A case report
Fan Zhang1, Yiya Yang, Yinyin Chen
1Department of Nephrology and Laboratory of Kidney Disease, Hunan Provincial People's Hospital, Hunan Normal University, Changsha, China.
Background:
Crescent formation is rare in primary membranous nephropathy (MN). The mechanism of crescent formation is unknown and the treatments are tentative.
Patient Concerns:
A 71-year-old woman presented with nephrotic syndrome, hematuria, and rapidly progressive kidney dysfunction.
Diagnosis:
Kidney biopsy was performed, and the diagnosis was MN in combination with crescentic glomerulonephritis. Circulating anti-PLA2R was detected of a high level.
Interventions:
The patient received rituximab besides corticosteroids.
Outcomes:
The patient achieved complete remission of proteinuria and recovery of kidney function.
Conclusion:
Our case suggests that there is a pathologic feature of MN and crescents in the absence of known immunologic factors as well as rituximab could serve as an effective cure and could be considered in serious MN conditions.
More Related Videos
06:46Author Spotlight: Understanding the Effect of Herbal-Cake-Separated Moxibustion in Rats with Renal Faliure
Published on: December 22, 2023
07:38Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
Related Concept Videos
Nephrotic Syndrome II : Assessment and Medical Management
Nephrotic Syndrome I : Introduction
Rheumatic Heart Disease III: Medical Management
Nephrotic Syndrome III : Nursing Management
Acute Pyelonephritis II: Diagnostic Studies and Management
Cardiomyopathy IV: Restrictive Cardiomyopathy